You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RAD001

Showing 26 - 50 of 470
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor Trial in United States (Adavosertib, Carboplatin, Everolimus)

Completed
Has Results
  • Advanced Malignant Solid Neoplasm
  • Aurora, Colorado
  • +7 more
Apr 11, 2022

Postmenopausal Women, Locally Advanced Metastatic Breast Cancer, Metastatic Breast Cancer Trial in Israel (Everolimus,

Completed
Has Results
  • Postmenopausal Women
  • +2 more
  • Jerusalem, Israel
  • +6 more
Mar 25, 2021

Waldenstrom's Macroglobulinemia Trial in Boston (Everolimus, Rituximab, Bortezomib)

Terminated
Has Results
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Apr 22, 2021

Breast Cancer Trial in Worldwide (ribociclib (LEE011), Exemestane, Everolimus (RAD001))

Completed
  • Breast Cancer
  • ribociclib (LEE011)
  • +2 more
  • Fayetteville, Arkansas
  • +12 more
Apr 8, 2021

Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor-negative Trial in Duarte, Rancho Cucamonga, South Pasadena

Completed
Has Results
  • Estrogen Receptor Negative
  • +4 more
  • Duarte, California
  • +2 more
Jun 6, 2022

Carcinoma, Renal Cell Trial in Worldwide (DFF332, RAD001, PDR001)

Recruiting
  • Carcinoma, Renal Cell
  • Duarte, California
  • +10 more
Jun 13, 2022

Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in

Completed
  • Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
  • PDR001
  • +5 more
  • Santa Monica, California
  • +24 more
Mar 11, 2022

Metastatic Renal Cell Carcinoma Trial in China (Everolimus (RAD001))

Completed
  • Metastatic Renal Cell Carcinoma
  • Everolimus (RAD001)
  • Wuhan, Hubei, China
  • +6 more
Dec 17, 2020

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • +4 more
  • Aurora, Colorado
  • +1 more
Sep 8, 2022

Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Lymphangioleiomyomatosis Trial in France, Italy, United States (Everolimus)

Completed
Has Results
  • Lymphangioleiomyomatosis
  • Boston, Massachusetts
  • +3 more
Nov 16, 2020

Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid

Recruiting
  • Atypical Endometrial Hyperplasia
  • +2 more
  • Greeley, Colorado
  • +17 more
Jun 13, 2022

Small-Cell Lung Cancer Trial in France, United States (Everolimus)

Completed
  • Small-Cell Lung Cancer
  • Fayetteville, Arkansas
  • +5 more
Dec 17, 2020

Non-Hodgkin's Lymphoma Trial in Japan (Everolmus)

Completed
  • Non-Hodgkin's Lymphoma
  • Nagoya-city, Aichi, Japan
  • +7 more
Dec 17, 2020

Neuroendocrine Tumors Trial in San Francisco (RAD001, erlotinib)

Terminated
Has Results
  • Neuroendocrine Tumors
  • San Francisco, California
    University of California, San Francisco
Sep 27, 2020

Breast Cancer Trial in Guangzhou (Everolimus, Letrozole, Fluorouracil)

Completed
  • Breast Cancer
  • Guangzhou, Guangdong, China
    Sun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
Sep 22, 2021

Advanced or Metastatic Pancreatic Adenocarcinoma Trial in Germany (everolimus)

Completed
  • Advanced or Metastatic Pancreatic Adenocarcinoma
  • Halle, Germany
  • +4 more
Dec 17, 2020

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • Atlanta, Georgia
  • +2 more
Mar 10, 2022

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Anakinra, Denosumab,

Completed
  • Advanced Malignant Neoplasm
  • +3 more
  • Anakinra
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 24, 2021

Advanced Solid Tumors, Metastatic Breast Cancer, Metastatic Renal Cell Carcinoma Trial in Worldwide (RAD001 + BEZ235)

Completed
  • Advanced Solid Tumors
  • +2 more
  • RAD001 + BEZ235
  • Fayetteville, Arkansas
  • +9 more
Dec 17, 2020

CD20+, B-cell Lymphomas, Mantle Cell Lymphoma, Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) Trial in Baltimore

Completed
Has Results
  • CD20+, B-cell Lymphomas
  • +5 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Oct 4, 2021

Renal Angiomyolipoma Trial in China (Everolimus)

Completed
Has Results
  • Renal Angiomyolipoma
  • Wuhan, Hubei, China
  • +4 more
Sep 3, 2021

Intracranial Meningioma Trial in United States (Everolimus, Bevacizumab)

Terminated
Has Results
  • Intracranial Meningioma
  • Orlando, Florida
  • +6 more
Nov 8, 2021

Breast Cancer, Triple Negative Breast Cancer Trial in Houston, Sugar Land (Everolimus)

Completed
Has Results
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Houston, Texas
  • +2 more
Jul 16, 2021

Non Small Cell Lung Cancer Trial in Worldwide (RAD001, erlotinib)

Completed
  • Non Small Cell Lung Cancer
  • Atlanta, Georgia
  • +13 more
Dec 17, 2020